RxDoctor Payments Data

Vanessa Bair, PA

Surgical · du Bois, PANPI 1922760032

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,188 of the $3,199 with a category attached, or 68.4%. 26 manufacturers reported payments, led by Si-bone, Inc. at 34.9% of the total. Reporting peaked in 2024 at $1,630 and has fallen 68.6% since, to $513 in 2025. Among surgical clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,199in general payments, 2019–2025

Across 84 payments — averaging $38.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$1K
  • Abbott$252
  • Nevro Corp.$248
  • AbbVie$212
  • Stryker$196
  • Medtronic$147
  • plus $1K from 20 others

What the payments were for

  • Travel & lodging$1,01132%
  • Food & beverage$2,18868%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,199 in reported general payments places this provider in the 90th percentile of 626 surgical providers in Pennsylvania.

See all surgical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$86,931
Medicare patients
250
Services billed
1,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate59$42,726
BelbucaBuprenorphine Hcl45$39,320
Buprenorphine92$16,333
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl119$9,785
Fentanyl39$7,578
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen207$5,653
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen238$5,571
Oxycodone Hcl339$5,085
MovantikNaloxegol Oxalate12$4,824
Buprenorphine Hcl91$4,708
Pregabalin154$3,984
Dronabinol17$3,074
Morphine Sulfate ErMorphine Sulfate54$2,855
Methadone Hcl54$1,370
Morphine Sulfate56$1,063

Paid to pharmacies, not to this prescriber.

Other surgical in du Bois

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →